Premium
P3‐450: Safety and pharmacokinetics following a single 10‐minute intravenous infusion of the anti‐amyloid mAb ponezumab (PF‐04360365) in patients with mild to moderate Alzheimer's disease
Author(s) -
Burstein Aaron H.,
Zhao Qinying,
Ross Joel,
Styren Scot,
Landen Jaren W.,
Ma Wendy M.,
McCush Frederick,
Alvey Christine,
Kupiec James T.,
Bednar Martin M.
Publication year - 2010
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2010.05.1992
Subject(s) - pharmacokinetics , medicine , cmax , adverse effect , pharmacology , headaches , gastroenterology , anesthesia , surgery